Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Polyrizon Ltd. ( (PLRZ) ) has issued an update.
On April 8, 2025, Polyrizon Ltd. received a notification from Nasdaq indicating non-compliance with the minimum bid price requirement, as their stock price had been below $1.00 for 30 consecutive business days. The company has until October 6, 2025, to regain compliance, during which time their shares will continue to be listed. If compliance is not achieved, they may receive an additional 180-day period to meet the requirements, failing which their shares could be delisted. Polyrizon is actively monitoring the situation and considering options to address the issue.
More about Polyrizon Ltd.
Polyrizon Ltd. is a development stage biotech company that specializes in innovative intranasal hydrogels. Their primary product is a nasal spray that forms a hydrogel-based shield to protect against viruses and allergens. The company is also working on technologies for the nasal delivery of active pharmaceutical ingredients.
YTD Price Performance: -80.27%
Average Trading Volume: 320,090
Technical Sentiment Signal: Strong Buy
See more data about PLRZ stock on TipRanks’ Stock Analysis page.